Results 121 to 130 of about 1,478 (160)

Management of post-menopausal vaginal atrophy and atrophic vaginitis

Maturitas, 2005
The involution of the female genital tract seems to reflect a built-in biological life expectancy, inter-related with the hypothalamic-hypophyseal-ovarian axis. Lower levels of oestradiol have a number of adverse effects, including on the lower urinary tract. The major universal change is vaginal atrophy.
Camil, Castelo-Branco, Maria Jesús, Cancelo, Jose, Villero, Francisco, Nohales, Maria Dolores, Juliá   +4 more
openaire   +2 more sources

Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause

Menopause, 2011
Vaginal atrophy caused by decreased levels of ovarian estrogen production is common at menopause. Atrophic vaginitis severe enough to result in vaginal stricture of the upper two thirds of the vagina and subsequent hematocolpos is unusual.A 53-year-old woman presented with nonvisualization of the cervix at the time of her annual examination.Pelvic ...
Saya, Segal, Heidi S, Harvie, Evan, Siegelman, Lily A, Arya   +3 more
openaire   +2 more sources

Atrophic Vaginitis in the Menopause

2014
Vulvovaginal atrophy and atrophic vaginitis are extremely common variants of lower genital tract states of estrogen deficiency affecting women of all socioepidemiologic strata worldwide. Recent molecular studies have emerged linking vaginal microbiota to vulvovaginal atrophy.
Ryan Sobel, Jack D. Sobel
openaire   +1 more source

Atrophic vaginitis signs, symptoms, and better outcomes

The Nurse Practitioner, 2011
Atrophic vaginitis is a common finding in women with low estrogen states. Many women believe their symptoms are expected signs of aging. NPs can provide therapeutic options to improve vaginal health and quality of life. This article reviews physiology, clinical manifestations, signs, symptoms, and treatment methods for atrophic vaginitis.
Annabelle, Reimer, Laura, Johnson
openaire   +2 more sources

Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis

Menopause, 2009
The aim of this study was to assess the efficacy and safety of intravaginal estriol and progesterone on atrophic vaginitis in postmenopausal women.Under a physician-sponsored Investigational New Drug application, 19 healthy postmenopausal women with atrophic vaginitis received vaginal suppositories containing estriol (1 mg) and progesterone (30 mg ...
Janet A, Chollet, Gloria, Carter, Leslie A, Meyn, Fred, Mermelstein, Judith L, Balk   +4 more
openaire   +2 more sources

Causes of and treatment for atrophic vaginitis

Independent Nurse, 2015
Vaginal dryness is a common, underdiagnosed condition that is easily treated, says Suneeta Kochhar
openaire   +1 more source

Diagnosis and treatment of atrophic vaginitis.

American family physician, 2000
Up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. Because the condition is attributable to estrogen deficiency, it may occur in premenopausal women who take antiestrogenic medications or who have medical or surgical conditions that result in decreased levels of estrogen. The thinned endometrium and increased vaginal pH level
G A, Bachmann, N S, Nevadunsky
openaire   +1 more source

Atrophic Vaginitis

2019
  +4 more sources

Atrophic Vaginitis

2020
Rhonda Arthur, Michelle Collins
openaire   +1 more source

[Topical treatment with estriol in postmenopausal atrophic vaginitis].

Revue francaise de gynecologie et d'obstetrique, 1990
The vaginal application of estriol leads to plasma free estriol levels validated on the basis of laboratory and clinical parameters at a dose very much less than that.
TOLINO, ACHILLE, RONSINI S, GRANATA P, GALLO FP, RICCIO S, MONTEMAGNO U.   +5 more
openaire   +2 more sources